Aspivix: Bringing Gentle Innovation in Women’s Health to Southern California
Aspivix is bringing Gentle Innovation in Women’s Health to Southern California
For decades, millions of women undergoing procedures like IUD insertions have heard the phrase, “It’s just a pinch.” That “pinch” comes from the use of the tenaculum, a sharp, century-old instrument that can cause pain and bleeding.
Aspivix, a FemTech company, is transforming this experience with carevix®, the world’s first suction-based cervical stabilizer. This FDA-cleared and CE-marked device offers a gentler, evidence-based alternative, reducing pain and bleeding while improving patient comfort during procedures such as IUD insertions, endocervical biopsies and even IVF treatments.
After successful clinical adoption in Europe, Aspivix has chosen Los Angeles and Orange County as the launchpad for its U.S. commercialization.
This region’s vibrant ecosystem of world-class institutions, innovative clinics, and forward-thinking practitioners makes it the ideal hub to introduce patient-centered technologies in women’s health.
The Southern California rollout will precede a nationwide expansion, bringing a gentler, evidence-based alternative to providers and patients across the country.
We’re excited to collaborate with local partners, clinicians, and innovators to improve the gynecological experience for women—one procedure at a time.
? Learn more: www.aspivix.com
? For healthcare providers only, access the e-shop: www.myaspivix.us
